In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
27mon MSN
Another judge in Washington halted the plan minutes before it was set to go into effect, but the short-term order is only in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback